BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 71 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,281 | -2.1% | 364 | +1.7% | 0.00% | – |
| Q2 2023 | $14,590 | -1.4% | 358 | +1.4% | 0.00% | – |
| Q1 2023 | $14,794 | -3.0% | 353 | +1.1% | 0.00% | -100.0% |
| Q4 2022 | $15,247 | -70.7% | 349 | -74.2% | 0.00% | -50.0% |
| Q3 2022 | $52,000 | +62.5% | 1,352 | +78.1% | 0.00% | +100.0% |
| Q2 2022 | $32,000 | -5.9% | 759 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -8.1% | 759 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $37,000 | +2.8% | 759 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -2.7% | 759 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $37,000 | +5.7% | 759 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | -2.8% | 759 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +9.1% | 759 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $33,000 | +10.0% | 759 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $30,000 | +66.7% | 759 | +46.5% | 0.00% | +100.0% |
| Q1 2020 | $18,000 | -18.2% | 518 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $22,000 | +46.7% | 518 | +34.5% | 0.00% | +100.0% |
| Q3 2019 | $15,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ahrens Investment Partners LLC | 74,825 | $3,561,000 | 1.91% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 40,961 | $1,174,000 | 0.99% |
| Diversified, LLC | 19,077 | $818,000 | 0.70% |
| CORRADO ADVISORS, LLC | 9,645 | $459,000 | 0.35% |
| Rikoon Group, LLC | 16,672 | $793,000 | 0.22% |
| Eudaimonia Partners, LLC | 8,240 | $392,000 | 0.09% |
| Arete Wealth Advisors, LLC | 10,658 | $507,000 | 0.07% |
| SOA Wealth Advisors, LLC. | 4,900 | $242,000 | 0.07% |
| Financial Advantage, Inc. | 833 | $39,000 | 0.04% |
| Jacobi Capital Management LLC | 4,184 | $199,000 | 0.03% |